e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
COPD: management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Validation and clinical application of a newly developed high-concentration oxygen-delivery device with a jet nebulizer function
K. Miyamoto, M. Takase, S. Fuke (Sapporo, Japan)
Source:
Annual Congress 2010 - COPD: management
Session:
COPD: management
Session type:
Thematic Poster Session
Number:
4019
Disease area:
Airway diseases, Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Miyamoto, M. Takase, S. Fuke (Sapporo, Japan). Validation and clinical application of a newly developed high-concentration oxygen-delivery device with a jet nebulizer function. Eur Respir J 2010; 36: Suppl. 54, 4019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Lane-hamilton syndrome and CCF: a fatal association
Related content which might interest you:
Characterization of the performance of a new portable jet nebulizer system for the delivery of budesonide suspension for nebulization
Source: Annual Congress 2008 - Wheezing in preschool children
Year: 2008
Characterization of the performance of a new DC powered jet nebulizer system when compared with AC powered jet nebulizer systems
Source: Annual Congress 2008 - Wheezing in preschool children
Year: 2008
Reduction of nebulization time can be achieved with a new jet nebulizer design
Source: Eur Respir J 2006; 28: Suppl. 50, 211s
Year: 2006
Aerosol delivery characteristics from a new jet nebulizer in comparison with commercially available jet nebulizers
Source: Annual Congress 2008 - Wheezing in preschool children
Year: 2008
A newly developed ultra-small portable oxygen concentrator with equivalent efficacy to the conventional device
Source: Virtual Congress 2020 – New insights into determinants of patient-reported outcomes in chronic respiratory diseases
Year: 2020
Impact of different ventilator parameters on in-vitro aerosol performance of a novel nebulizer for ventilated patients
Source: Annual Congress 2009 - Airway management, mechanical ventilation and muscle weakness
Year: 2009
Development of in-vitro models for aerosolized surfactant therapy to support customization of a novel nebulizer system based on eflow technology
Source: Annual Congress 2009 - Respiratory disorders of the newborn
Year: 2009
Performance characteristics of a new nebulizer for heliox
Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence
Year: 2007
A preliminary assessment of the stability of 5-CF containing liposomes following aerosolisation with TouchSprayÔ technology and a commercial jet nebuliser
Source: Eur Respir J 2003; 22: Suppl. 45, 471s
Year: 2003
In vitro performance of the prodose AAD® handheld - a new portable aerosol delivery system
Source: Eur Respir J 2004; 24: Suppl. 48, 581s
Year: 2004
Performance of a novel humidification device for high flow oxygen therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 189s
Year: 2006
A new tool for monitoring patient adherence with aerosol therapy using an eflow nebulizer system
Source: Annual Congress 2009 - Treatment of airways disease
Year: 2009
Comparison of a portable device versus a specific spirometer for cough flow testing
Source: International Congress 2017 – Chronic airway disease: markers of disease impact
Year: 2017
Reduction in nebulisation time of aqueous drug solutions by the eFlow rapid in comparison to a jet nebuliser to improve patient convenience and compliance
Source: Eur Respir J 2005; 26: Suppl. 49, 338s
Year: 2005
Measurement of respiratory function with a mobile application: comparison with a conventional spirometer and evaluation of usability
Source: International Congress 2019 – M-health/e-health I
Year: 2019
The performance of a prototype novel humidification device during mechanical ventilation
Source: Eur Respir J 2006; 28: Suppl. 50, 179s
Year: 2006
Validation study of the AirGo™ device for continuous monitoring of respiratory function
Source: International Congress 2018 – New methods and concepts in tests of lung and respiratory muscle function
Year: 2018
Validation of a portable blood gas analyzer for use in challenging field conditions
Source: International Congress 2019 – Cardiopulmonary exercise testing
Year: 2019
Consistency of aerosol characteristics at low flow rates for a novel mesh nebulizer
Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies
Year: 2018
In vitro
characterisation of a novel electronic nebulizer utilising a customised single dose bfs-vial to improve handling and delivery performance
Source: Annual Congress 2009 - New aspects of inhalation therapy
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept